tricalcium phosphate has been researched along with Coronary Artery Disease in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Anokhina, V; Bushinsky, DA; Chen, W; Estrella, MM; Fitzpatrick, J; Jaar, BG; Melamed, ML; Miller, BL; Monroy-Trujillo, JM; Parekh, RS; Serrano, J; Sozio, SM | 1 |
| Desai, RJ; Kim, SC; Paik, JM; Schneeweiss, S; Spoendlin, J; Tsacogianis, T | 1 |
| Nakahara, T; Narula, J; Narula, N; Strauss, HW | 1 |
| Mason, MA; Shepler, BM | 1 |
| Bianchi, CF; Buchholz, B; Gao, F; Gu, Z; Laham, R; Ma, X; McCarthy, S; Oyamada, S; Robich, MP; Sellke, FW; Wang, X; Wu, H; Wu, T | 1 |
| Böhm, M; Cremers, B; Ege, P; Fehrenz, M; Fliser, D; Heine, GH; Hornof, F; Jeken, J; Kersting, S; Rebling, NM; Rogacev, KS; Scheller, B; Seiler, S; Steimle, C | 1 |
| Chang, HJ; Cho, I; Choi, BW; Chung, N; Ha, JW; Jang, Y; Kim, KJ; Kim, YJ; Lim, SK; Rhee, Y; Shim, CY; Shin, S; Yang, WI | 1 |
| Bellasi, A; Block, GA; Kooienga, L; Raggi, P; Spiegel, DM | 1 |
| Descombes, E; Nguyen, QV | 1 |
| Bertrand, OF; Frattolin, J; Mongrain, R; Rajagopalan, S; Roy, R; Walsh, M; Yue, S | 1 |
| Hiruta, N; Kobayashi, T; Nakagawa, O; Shimoyama, E; Shirai, S; Uchida, Y | 1 |
| Chen, J; Feng, G; He, S; Jiang, X; Kislauskis, E; Laham, R; Lan, Z; Lyu, Y; McCarthy, S; Wang, S; Wu, T; Xiao, J; Zhang, Y; Zheng, X | 1 |
| Pasch, A | 1 |
| Li, Y; Lou, C; Wang, X | 1 |
| Chen, J; Gu, Y; Hao, C; Li, H; Li, M; Lu, Y; Zhang, Q | 1 |
| Detrano, R; Garner, D; Gutfinger, D; Kang, X; Mahaisavariya, P; McCrae, M; Measham, C; Molloi, S; Peng, SK; Tang, W | 1 |
| Detrano, R; Molloi, S | 1 |
4 review(s) available for tricalcium phosphate and Coronary Artery Disease
| Article | Year |
|---|---|
Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Topics: Calcinosis; Calcium; Calcium Phosphates; Calcium, Dietary; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Artery Disease; Disease Progression; Humans; Hyperphosphatemia; Phosphates; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Novel assessments of systemic calcification propensity.
Topics: alpha-2-HS-Glycoprotein; Aorta; Calcinosis; Calcium; Calcium Phosphates; Coronary Artery Disease; Graft Survival; Humans; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Transplantation; Minerals; Phosphates; Prognosis; Vascular Calcification; Vascular Stiffness | 2016 |
Meta-analysis comparing sevelamer and calcium-based phosphate binders on cardiovascular calcification in hemodialysis patients.
Topics: Biomarkers; Calcinosis; Calcium Phosphates; Chelating Agents; Comorbidity; Coronary Artery Disease; Drug-Related Side Effects and Adverse Reactions; Humans; Incidence; Polyamines; Renal Dialysis; Risk Assessment; Sevelamer | 2010 |
Radiographically detectable calcium and atherosclerosis: the connection and its exploitation.
Topics: Calcinosis; Calcium Phosphates; Coronary Artery Disease; Coronary Vessels; Fluoroscopy; Humans; Time Factors; Tomography, X-Ray Computed | 1992 |
1 trial(s) available for tricalcium phosphate and Coronary Artery Disease
| Article | Year |
|---|---|
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
Topics: Adult; Aged; Calcinosis; Calcium Phosphates; Coronary Artery Disease; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer | 2007 |
12 other study(ies) available for tricalcium phosphate and Coronary Artery Disease
| Article | Year |
|---|---|
Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
Topics: Adult; Aged; alpha-2-HS-Glycoprotein; Ankle Brachial Index; Aortic Diseases; Calcium Phosphates; Cohort Studies; Coronary Artery Disease; Female; Humans; Kidney Failure, Chronic; Linear Models; Longitudinal Studies; Male; Middle Aged; Mortality; Nanoparticles; Particle Size; Proportional Hazards Models; Prospective Studies; Pulse Wave Analysis; Renal Dialysis; Time Factors; Vascular Calcification; Vascular Stiffness | 2021 |
Cardiovascular Outcomes of Calcium-Free vs Calcium-Based Phosphate Binders in Patients 65 Years or Older With End-stage Renal Disease Requiring Hemodialysis.
Topics: Aged; Calcinosis; Calcium Phosphates; Chelating Agents; Cohort Studies; Coronary Artery Disease; Female; Humans; Hyperphosphatemia; Male; Propensity Score; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; United States | 2019 |
Vascular Calcification: The Evolving Relationship of Vascular Calcification to Major Acute Coronary Events.
Topics: Aged; Calcium; Calcium Phosphates; Chemotaxis; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Endothelial Cells; Female; Humans; Inflammation; Lipids; Lipoproteins, LDL; Macrophages; Male; Monocytes; Necrosis; Phosphorus; Plaque, Atherosclerotic; Proteoglycans; Solubility; Tomography, X-Ray Computed; Vascular Calcification | 2019 |
Paclitaxel/sirolimus combination coated drug-eluting stent: in vitro and in vivo drug release studies.
Topics: Animals; Antineoplastic Agents; Aorta, Abdominal; Calcium Phosphates; Coronary Artery Disease; Coronary Restenosis; Drug Combinations; Drug-Eluting Stents; Kinetics; Lactic Acid; Male; Microscopy, Electron, Scanning; Paclitaxel; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Sirolimus; Solubility; Surface Properties; Tubulin Modulators | 2011 |
The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation.
Topics: Atrial Fibrillation; Biomarkers; Calcium Phosphates; Coronary Artery Disease; Cross-Sectional Studies; Electrocardiography; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Dysfunction, Left | 2011 |
Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography.
Topics: Calcium; Calcium Phosphates; Coronary Angiography; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Multidetector Computed Tomography; Phosphates; Plaque, Atherosclerotic; Retrospective Studies; Vascular Calcification | 2012 |
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
Topics: Calcinosis; Calcium Phosphates; Chelating Agents; Coronary Artery Disease; Humans; Polyamines; Renal Dialysis; Sevelamer | 2008 |
A manufacturing and annealing protocol to develop a cold-sprayed Fe-316L stainless steel biodegradable stenting material.
Topics: Biocompatible Materials; Calcium Phosphates; Cold Temperature; Coronary Artery Disease; Corrosion; Humans; Isotonic Solutions; Materials Testing; Microscopy, Electron, Scanning; Pressure; Prosthesis Design; Stainless Steel; Stents; Stress, Mechanical; Tensile Strength; X-Ray Diffraction | 2019 |
Fluorescent angioscopic imaging of calcium phosphate tribasic: precursor of hydroxyapatite, the major calcium deposit in human coronary plaques.
Topics: Aged; Angioscopy; Autopsy; Azo Compounds; Biomarkers; Calcium Phosphates; Collagen Type I; Coronary Artery Disease; Coronary Vessels; Durapatite; Female; Fluorescent Dyes; Humans; Luminescent Measurements; Male; Middle Aged; Necrosis; Optical Imaging; Plaque, Atherosclerotic; Predictive Value of Tests; Vascular Calcification | 2017 |
Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease.
Topics: Animals; Biocompatible Materials; Calcium Phosphates; Calorimetry, Differential Scanning; Coronary Artery Disease; Coronary Vessels; Drug-Eluting Stents; Female; Lactic Acid; Male; Materials Testing; Nanoparticles; Paclitaxel; Polyesters; Polymers; Radiography; Swine; Swine, Miniature | 2014 |
Gastrodin Pretreatment Impact on Sarcoplasmic Reticulum Calcium Transport ATPase (SERCA) and Calcium Phosphate (PLB) Expression in Rats with Myocardial Ischemia Reperfusion.
Topics: Animals; Benzyl Alcohols; Calcium; Calcium Phosphates; Calcium-Binding Proteins; Coronary Artery Disease; Glucosides; Male; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2016 |
Accurate coronary calcium phosphate mass measurements from electron beam computed tomograms.
Topics: Algorithms; Calcium; Calcium Phosphates; Chemical Precipitation; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Durapatite; Electrons; Humans; Image Processing, Computer-Assisted; Models, Structural; Regression Analysis; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed | 1995 |